Veracyte financials
$46.08+1.88%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M | $219.5M | $117.5M | $120.4M | $92.0M | $72.0M | $65.1M |
| Gross profit | $362.5M | $298.1M | $229.7M | $175.7M | $145.1M | $76.0M | $83.8M | $58.9M | $43.8M | $39.6M |
| Gross margin | 70.1% | 66.9% | 63.6% | 59.2% | 66.1% | 64.7% | 69.7% | 64.0% | 60.8% | 60.9% |
| Operating income | $57.8M | $16.1M | -$85.8M | -$41.1M | -$81.9M | -$35.4M | -$15.1M | -$22.2M | -$26.5M | -$28.8M |
| Net income | $66.4M | $24.1M | -$74.4M | -$36.6M | -$75.6M | -$34.9M | -$12.6M | -$23.0M | -$31.0M | -$31.4M |
| Net margin | 12.8% | 5.4% | −20.6% | −12.3% | −34.4% | −29.7% | −10.5% | −25.0% | −43.1% | −48.2% |
| Diluted EPS | $0.82 | $0.31 | $-1.02 | $-0.51 | $-1.11 | $-0.66 | $-0.27 | $-0.62 | $-0.91 | $-1.09 |
| EBITDA | $99.7M | $43.0M | $9.7M | -$11.8M | -$62.3M | -$27.4M | -$11.0M | -$18.3M | -$22.7M | -$25.3M |
| Operating cash flow | $136.3M | $75.1M | $44.2M | $7.4M | -$32.4M | -$11.2M | -$3.2M | -$13.5M | -$23.9M | -$28.0M |
| Free cash flow | $126.6M | $63.8M | $34.3M | -$1.2M | -$37.8M | -$14.1M | -$6.0M | -$15.4M | -$25.7M | -$32.2M |
| Diluted shares | 80.6M | 78.2M | 72.6M | 71.5M | 67.9M | 53.2M | 46.1M | 37.0M | 33.9M | 28.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $362.6M | $239.1M | $216.5M | $154.2M | $173.2M | $349.4M |
| Short-term investments | $50.3M | $50.4M | $0.00 | $24.6M | $4.0M | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $810.0K |
| Total assets | $1.41B | $1.30B | $1.11B | $1.16B | $1.19B | $457.2M |
| Total liabilities | $96.4M | $124.1M | $70.8M | $81.2M | $91.3M | $35.9M |
| Shareholders' equity | $1.31B | $1.18B | $1.04B | $1.08B | $1.10B | $421.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology